• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的流行病学与自然史

Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.

作者信息

Satapathy Sanjaya K, Sanyal Arun J

机构信息

Division of Surgery, Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, Tennessee.

Division of Gastroenterology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia.

出版信息

Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.

DOI:10.1055/s-0035-1562943
PMID:26378640
Abstract

The epidemic of obesity has resulted in a parallel incremental burden of nonalcoholic fatty liver disease (NAFLD) worldwide. Nonalcoholic fatty liver disease includes a spectrum of liver disease that ranges from simple fat accumulation in the liver to necroinflammation, fibrosis, cirrhosis, and hepatocellular carcinoma, which in essence represent the stages of the natural history of NAFLD. The rising prevalence of NAFLD globally may be accounted for by changes in dietary habits and an increase in sedentary lifestyle. Nonalcoholic steatohepatitis (NASH), the aggressive form of NAFLD, is currently the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. In the current review, the authors discuss the uncertainty around the progression from NAFL (steatosis) to NASH (steatohepatitis), the undisputed progression of NASH to cirrhosis, and the risk factors that predispose to such progression. The published literature on the long-term cardiovascular complications and liver-related mortality of NAFLD is also discussed.

摘要

肥胖症的流行在全球范围内导致了非酒精性脂肪性肝病(NAFLD)负担的相应增加。非酒精性脂肪性肝病包括一系列肝脏疾病,从肝脏单纯脂肪堆积到坏死性炎症、纤维化、肝硬化和肝细胞癌,这些实质上代表了NAFLD自然病程的各个阶段。全球NAFLD患病率的上升可能是由于饮食习惯的改变和久坐不动生活方式的增加。非酒精性脂肪性肝炎(NASH)是NAFLD的侵袭性形式,目前是美国等待肝移植的成年人中第二大肝病病因。在当前的综述中,作者讨论了从NAFL(脂肪变性)进展到NASH(脂肪性肝炎)的不确定性、NASH发展为肝硬化这一无可争议的过程以及易导致这种进展的危险因素。还讨论了关于NAFLD长期心血管并发症和肝脏相关死亡率的已发表文献。

相似文献

1
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学与自然史
Semin Liver Dis. 2015 Aug;35(3):221-35. doi: 10.1055/s-0035-1562943. Epub 2015 Sep 17.
2
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎:肝移植的相关影响。
Liver Transpl. 2018 Feb;24(2):166-170. doi: 10.1002/lt.25003.
3
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
4
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.非肝硬化非酒精性脂肪性肝病和代谢综合征背景下的肝细胞癌:美国的经验
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
5
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults.成人非酒精性脂肪性肝病的进展和自然史。
Clin Liver Dis. 2016 May;20(2):313-24. doi: 10.1016/j.cld.2015.10.010. Epub 2015 Dec 24.
6
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.非酒精性脂肪性肝病相关肝细胞癌:一个日益严重的问题。
Semin Liver Dis. 2015 Aug;35(3):304-17. doi: 10.1055/s-0035-1562949. Epub 2015 Sep 17.
7
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.非酒精性脂肪性肝病向肝硬化的进展率及肝硬化向失代偿和死亡率的进展:医疗保险数据的真实世界分析。
Aliment Pharmacol Ther. 2020 Jun;51(11):1149-1159. doi: 10.1111/apt.15679. Epub 2020 May 5.
8
[Advances in diagnosis and treatment of nonalcoholic fatty liver disease].[非酒精性脂肪性肝病的诊断与治疗进展]
Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):81-4. doi: 10.3760/cma.j.issn.1007-3418.2016.02.001.
9
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现:最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
10
Non-invasive biomarkers in non-alcoholic steatohepatitis-induced hepatocellular carcinoma.非酒精性脂肪性肝炎诱导的肝细胞癌中的非侵入性生物标志物。
J Gastrointestin Liver Dis. 2014 Dec;23(4):425-9. doi: 10.15403/jgld.2014.1121.234.bna.

引用本文的文献

1
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives.代谢功能障碍相关脂肪性肝病患者的肝脏硬度测量:方法有效性及前景的最新进展
World J Hepatol. 2025 Jul 27;17(7):106675. doi: 10.4254/wjh.v17.i7.106675.
2
Contributions of Noncardiac Organ-Heart Immune Crosstalk and Somatic Mosaicism to Heart Failure: Current Knowledge and Perspectives.非心脏器官-心脏免疫串扰和体细胞镶嵌现象对心力衰竭的影响:当前认知与展望
Circ Res. 2025 May 23;136(11):1208-1232. doi: 10.1161/CIRCRESAHA.125.325489. Epub 2025 May 22.
3
Potential bidirectional communication between the liver and the central circadian clock in MASLD.
非酒精性脂肪性肝炎中肝脏与中枢昼夜节律时钟之间潜在的双向通讯。
NPJ Metab Health Dis. 2025;3(1):15. doi: 10.1038/s44324-025-00058-1. Epub 2025 Apr 9.
4
GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease.生长分化因子15循环水平与代谢相关肝损伤及动脉粥样硬化性心血管疾病相关。
Int J Mol Sci. 2025 Feb 26;26(5):2039. doi: 10.3390/ijms26052039.
5
Anthropometric Indices and Metabolic Dysfunction-Associated Fatty Liver Disease in Males and Females Living With Severe Obesity.重度肥胖男性和女性的人体测量指数与代谢功能障碍相关脂肪性肝病
Can J Gastroenterol Hepatol. 2025 Feb 16;2025:5545227. doi: 10.1155/cjgh/5545227. eCollection 2025.
6
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.肝细胞癌:手术治疗与不断发展的治疗策略。
Cancer Treat Res. 2024;192:185-206. doi: 10.1007/978-3-031-61238-1_10.
7
The newly proposed plasma-glycosylated hemoglobin A1c/High-Density lipoprotein cholesterol ratio serves as a simple and practical indicator for screening metabolic associated fatty liver disease: an observational study based on a physical examination population.新提出的血浆糖化血红蛋白 A1c/高密度脂蛋白胆固醇比值可作为筛查代谢相关性脂肪性肝病的简单实用指标:一项基于体检人群的观察性研究。
BMC Gastroenterol. 2024 Aug 19;24(1):274. doi: 10.1186/s12876-024-03362-0.
8
A Healthful Plant-Based Diet as an Alternative Dietary Approach in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease.以植物为主的健康饮食作为代谢功能障碍相关脂肪性肝病治疗中替代饮食方法的一种选择。
Nutrients. 2024 Jun 26;16(13):2027. doi: 10.3390/nu16132027.
9
Pleiotropic Action of TGF-Beta in Physiological and Pathological Liver Conditions.转化生长因子-β在生理性和病理性肝脏状况下的多效性作用
Biomedicines. 2024 Apr 22;12(4):925. doi: 10.3390/biomedicines12040925.
10
Investigating the causal associations between five anthropometric indicators and nonalcoholic fatty liver disease: Mendelian randomization study.探究五项人体测量指标与非酒精性脂肪性肝病之间的因果关联:孟德尔随机化研究
World J Clin Cases. 2024 Mar 6;12(7):1215-1226. doi: 10.12998/wjcc.v12.i7.1215.